Impact fact

Barry has been involved in the launch of over 75 new molecular entities globally. He is passionate in partnering with his clients and playing a role in expediting patient access to innovative therapies.


As the leader of ZS’s value and access practice, Barry develops solutions that enable clients to achieve market access for their innovations. While he maintains a significant focus on client delivery, his responsibilities extend to providing over-arching leadership for the practice’s activities.


Barry has more than 17 years of experience helping global pharmaceutical and biotech clients gain innovation access. Most of his career he has focused on developing integrated market access solutions to create innovative and impactful outcomes for clients. At ZS, Barry ensures that insight and strategy are translated into real and tangible value, allowing our clients to ensure that the needs of the access ecosystem are holistically addressed in an integrated way. In doing so, value is defined, discovered and delivered by his team.

Prior experience

Before joining ZS, Barry was the global head of pricing and market access at PAREXEL International, where he grew the team into a strategy group focused on developing integrated market access solutions. Prior to that he started his consulting journey for IMS P&R/Cambridge Pharma, and spent time at the Associate Parliamentary Group in Westminster and the NHS’s Modernization agency, gathering critical real-world experience in policy development and healthcare provision within the U.K.


Barry holds a B.S. degree in medical microbiology from Newcastle University and a MSc in medical diagnostics and advanced technologies from Cranfield University's Institute of BioScience and Technology.